Richard Scolyer leaves a unique legacy of pioneering brain cancer research · Briflio

BriflioWorld in a Pulse

HealthKnowledge Pulse

Richard Scolyer leaves a unique legacy of pioneering brain cancer research

Scolyer captured the world’s attention when he volunteered for a world-first experimental treatment for brain cancer.

Read the full pulse→

Continue in Briflio to read, react, comment, and share.

Sources

The Conversation: Richard Scolyer leaves a unique legacy of pioneering brain cancer research — by Sarah Diepstraten, Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research), John (Eddie) La Marca, Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)

Read quickly · Share thoughtfully · Learn deeper